Azathioprine, belimumab, cyclosporine, everolimus, mycophenolate, pimecrolimus, sirolimus, and tacrolimus.
Pharmacologic Profile
General Use
Azathioprine, cyclosporine, everolimus, mycophenolate, sirolimus, and tacrolimus are used with corticosteroids in the prevention of transplantation rejection reactions. Azathioprine and cyclosporine are also used in the management of selected autoimmune diseases (nephrotic syndrome of childhood and severe rheumatoid arthritis). Belimumab is used for the treatment of lupus nephritis and systemic lupus erythematosus. Pimecrolimus is used in the treatment of atopic dermatitis.
General Action and Information
Inhibit cell-mediated immune responses by different mechanisms. In addition to azathioprine and cyclosporine, which are used primarily for their immunomodulating properties, cyclophosphamide and methotrexate are used to suppress the immune responses in certain disease states (nephrotic syndrome of childhood and severe rheumatoid arthritis).
Contraindications
Hypersensitivity to drug or vehicle.
Precautions
Use cautiously in patients with infections.
Interactions
Allopurinol inhibits the metabolism of azathioprine. Drugs that alter liver-metabolizing processes may change the effect of cyclosporine, tacrolimus, or sirolimus. The risk of toxicity with methotrexate may be ↑ by other nephrotoxic drugs, large doses of aspirin, or NSAIDs.
Nursing Implications
Assessment
Implementation
Patient/Family Teaching
Evaluation/Desired Outcomes